EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy

Anni Saarela iD, Oskari Timonen, Jarkko Kirjavainen, Yawu Liu, Katri Silvennoinen, Esa Mervaala, Reetta Kälviäinen

Epileptic Disorders · 2024

DOI: 10.1002/epd2.20244 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Epileptic Disorders, 2024. Verfasst von Anni Saarela und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Kuopio Epilepsy Center., Kuopio University Hospital. Full Member of ERN EpiCARE., Kuopio, Finland. Hauptthemen laut MEDLINE: Malformations of Cortical Development, Epilepsy, Laminin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saastamoinen Foundation, Vaajasalo Foundation, Finnish Government Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Recessive LAMC3 mutations are recognized to cause epilepsy with cortical malformations characterized by polymicrogyria and pachygyria. The objective of this study was to describe the clinical picture and epilepsy phenotype of four patients with a previously undescribed LAMC3 variant.

Methods

All epilepsy patients treated in Kuopio Epilepsy Center (located in Kuopio, Finland) are offered the possibility to participate in a scientific study investigating biomarkers in epilepsy (Epibiomarker study). We have collected a comprehensive database of the study population, and are currently re‐evaluating our database regarding the patients with developmental and/or epileptic encephalopathy (DEE). If the etiology of epilepsy remains unknown in the clinical setting, we are performing whole exome sequencing to recognize the genetic causes.

Results

Among our study population of 323 DEE patients we recognized three patients with similar homozygous LAMC3 c.1866del (p.(Phe623Serfs*10)) frameshift variant and one patient with a compound heterozygous mutation where the same frameshift variant was combined with an intronic LAMC3 c.4231‐12C>G variant on another allele. All these patients have severe epilepsy and either bilateral agyria‐pachygyria or bilateral polymicrogyria in their clinical MRI scanning. Cortical malformations involve the occipital lobes in all our patients. Epilepsy phenotype is variable as two of our patients have DEE with epileptic spasms progressing to Lennox–Gastaut syndrome and intellectual disability. The other two patients have focal epilepsy without marked cognitive deficit. The four patients are unrelated. LAMC3 c.1866del p.(Phe623Serfs*10) frameshift variant is enriched in the Finnish population. Significance Only a few patients with epilepsy caused by LAMC3 homozygous or compound heterozygous mutations have been described in the literature. To our knowledge, the variants discovered in our patients have not previously been published. Clinical phenotype appears to be more varied than previously assumed and patients with a milder phenotype and normal cognition have probably remained unrecognized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malformations of Cortical DevelopmentEpilepsyLamininHumansFinlandFemaleMaleChildChild, PreschoolPhenotypeAdolescentMutation

Stichwörter der Autor:innen

agyria (HPO 0031882)atonic seizure (HPO 0010819)atypical absence seizure (HPO 0007270)atypical absence status epilepticus (HPO 0011151)bilateral tonic–clonic seizure (HPO 0002069)epileptic spasm (HPO 0011097)focal‐onset seizure (HPO 0007359)pachygyria (HPO 0001302)polymicrogyria (HPO 0002126)tonic seizure (HPO 0032792)

Substanzen

Laminin

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Kuopio Epilepsy Center., Kuopio University Hospital. Full Member of ERN EpiCARE., Kuopio, Finland.
  • Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Department of Neurology, Kuopio Epilepsy Center, Kuopio University Hospital. Full Member of ERN EpiCARE, Kuopio, Finland.
  • Department of Clinical Neurophysiology, Kuopio Epilepsy Center, Kuopio University Hospital. Full Member of ERN EpiCARE, Kuopio, Finland.

ORCID-Profile: Anni Saarela

Förderung

  • Saastamoinen Foundation
  • Vaajasalo Foundation
  • Finnish Government Research Funding
  • Saastamoisen säätiö

Zitieren

APA

Saarela, A., Timonen, O., Kirjavainen, J., Liu, Y., Silvennoinen, K., Mervaala, E., & Kälviäinen, R. (2024). Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy. Epileptic Disorders. https://doi.org/10.1002/epd2.20244

Vancouver

Saarela A, Timonen O, Kirjavainen J, Liu Y, Silvennoinen K, Mervaala E, et al. Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy. Epileptic Disorders. 2024. doi:10.1002/epd2.20244

BibTeX
@article{Saarela2024,
  author = {Saarela, Anni and Timonen, Oskari and Kirjavainen, Jarkko and Liu, Yawu and Silvennoinen, Katri and Mervaala, Esa and Kälviäinen, Reetta},
  title = {Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy},
  journal = {Epileptic Disorders},
  year = {2024},
  doi = {10.1002/epd2.20244}
}
Kostenlos starten →